| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.8% | 0.8% |
| Div Cover | 18.6 | 14.8 |
| Op Mrgn | 34.1% | 28.0% |
| ROCE | 51.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | 6.5 | 7.6 |
| PEG | 0.1 | n/a |
| Pr/Revenue | 1.7 | 1.6 |
| Pr/Book | 1.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 35.0% | 4.9% |
| PBT | 51.4% | -11.3% |
| EPS | 54.9% | -14.8% |
| DPS | 25.0% | 6.8% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-07 | 9.92 | 2.19 | 11.98p | 21.8 | 0.2 | +93% | 1.25p | 0.5% |
| 31-Mar-08 | 16.47 | 3.76 | 14.17p | 12.2 | 0.7 | +18% | 1.50p | 0.9% |
| 31-Mar-09 | 24.94 | 4.78 | 16.92p | 11.7 | 0.6 | +19% | 1.65p | 0.8% |
| 31-Mar-10 | 37.16 | 10.99 | 30.02p | 25.5 | 0.3 | +77% | 2.00p | 0.3% |
| 31-Mar-11 | 50.16 | 16.64 | 46.49p | 17.9 | 0.3 | +55% | 2.50p | 0.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-12 | 52.64 | 14.75 | 39.62p | 7.6 | n/a | -15% | 2.67p | 0.8% |
| 31-Mar-13 | 54.45 | 15.84 | 43.05p | 7.0 | 0.8 | +9% | 3.04p | 1.0% |
| 31-Mar-14 | 57.36 | 16.90 | 43.02p | 7.0 | n/a | -0% | 2.90p | 0.9% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| IDS Receives Prestigious Queens Award | 23-Apr-2012 | 11:02 | RNS-R |
| Trading Statement | 12-Apr-2012 | 07:00 | RNS |
| Holding(s) in Company | 04-Apr-2012 | 09:56 | RNS |
| Immunodiagnostic on track to met revenue targets | 12-Apr-2012 | ShareCast |
| DS Smith non-exec tops up his stake | 30-Jan-2012 | ShareCast |
| Imagination Technologies CEO makes multi-million... | 27-Jan-2012 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 300.00p |
| Change Today | -15.00p |
| % Change | -4.76 % |
| 52 Week High | 1,218.00p |
| 52 Week Low | 288.75p |
| Volume | 13,358 |
| Shares Issued | 28.34m |
| Market Cap | £85.01m |
| Beta | 0.24 |
| RiskGrade | 255 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 0 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 31-Aug-11 | 18-Aug-10 |
| Paid | 29-Sep-11 | 15-Sep-10 |
| Amount | 2.50p | 2.00p |
| Time | Volume / Share Price |
| 16:31 | 3,600 @ 310.20p |
| 16:35 | 661 @ 300.00p |
| 16:28 | 86 @ 300.00p |
| 15:21 | 110 @ 295.15p |
| 15:21 | 800 @ 300.25p |
| Finance Director | Paul Hailes |
| CEO | Christopher Ian Cookson |
You are here: research